psalexa
P&S Market Research - A market research firm

Presbyopia Therapeutics Pipeline Analysis

Presbyopia Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11273
Available Format:

Presbyopia is a type of vision disorder that results in the inability to focus up close. The disease is associated with the refraction problem in the eye. Refraction can be defined as the bending of the light when it passes through one medium to another. Light rays are refracted by cornea and lens which focuses directly on the retina that converts light rays into messages through the optic nerve to the brain. Presbyopia is one of the disorders that is associated with aging. Due to hardening of eye lenses, the eye loses its ability to focus the light on the retina. Allergan plc is in the process of developing AGN-199201 as an alpha 1 adrenergic receptor agonist for the treatment of presbyopia. Presbyopia Therapies, LLC is in the process of developing PRX-100 as an adrenergic receptor agonist for the treatment of presbyopia. Some of the companies having the pipeline of presbyopia include Presbyopia Therapies, LLC, Allergan plc, and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry